Cigarettes are one of the deadliest products on the market – but the risks of alternatives are not always clearly understood.
Shared Vision, Collective Impact, and Persistent Challenges: The First Decade of Georgia's Oncology Research Network Less than 5% of all adult patients with cancer enter clinical trials. These rates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results